chr3-63912699-A-C

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The NM_001377405.1(ATXN7):​c.101A>C​(p.Gln34Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000129 in 1,173,338 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Q34R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000089 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00013 ( 1 hom. )

Consequence

ATXN7
NM_001377405.1 missense

Scores

1
1
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.625

Publications

0 publications found
Variant links:
Genes affected
ATXN7 (HGNC:10560): (ataxin 7) The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA types I-III. ADCAI is genetically heterogeneous, with five genetic loci, designated spinocerebellar ataxia (SCA) 1, 2, 3, 4 and 6, being assigned to five different chromosomes. ADCAII, which always presents with retinal degeneration (SCA7), and ADCAIII often referred to as the 'pure' cerebellar syndrome (SCA5), are most likely homogeneous disorders. Several SCA genes have been cloned and shown to contain CAG repeats in their coding regions. ADCA is caused by the expansion of the CAG repeats, producing an elongated polyglutamine tract in the corresponding protein. The expanded repeats are variable in size and unstable, usually increasing in size when transmitted to successive generations. This locus has been mapped to chromosome 3, and it has been determined that the diseased allele associated with spinocerebellar ataxia-7 contains 37-306 CAG repeats (near the N-terminus), compared to 4-35 in the normal allele. The encoded protein is a component of the SPT3/TAF9/GCN5 acetyltransferase (STAGA) and TBP-free TAF-containing (TFTC) chromatin remodeling complexes, and it thus plays a role in transcriptional regulation. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2016]
ATXN7 Gene-Disease associations (from GenCC):
  • spinocerebellar ataxia 7
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • spinocerebellar ataxia type 7
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.080055594).
BS2
High AC in GnomAd4 at 13 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001377405.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATXN7
NM_001377405.1
MANE Select
c.101A>Cp.Gln34Pro
missense
Exon 3 of 13NP_001364334.1O15265-1
ATXN7
NM_001177387.1
c.101A>Cp.Gln34Pro
missense
Exon 2 of 13NP_001170858.1O15265-2
ATXN7
NM_000333.4
c.101A>Cp.Gln34Pro
missense
Exon 3 of 13NP_000324.1O15265-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATXN7
ENST00000674280.1
MANE Select
c.101A>Cp.Gln34Pro
missense
Exon 3 of 13ENSP00000501377.1O15265-1
ATXN7
ENST00000295900.10
TSL:1
c.101A>Cp.Gln34Pro
missense
Exon 3 of 13ENSP00000295900.6O15265-1
ATXN7
ENST00000522345.2
TSL:2
c.101A>Cp.Gln34Pro
missense
Exon 1 of 12ENSP00000428067.2O15265-2

Frequencies

GnomAD3 genomes
AF:
0.0000888
AC:
13
AN:
146350
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000125
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000677
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000211
Gnomad FIN
AF:
0.000111
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000604
Gnomad OTH
AF:
0.000496
GnomAD2 exomes
AF:
0.0000769
AC:
2
AN:
26008
AF XY:
0.000138
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000134
AC:
138
AN:
1026882
Hom.:
1
Cov.:
32
AF XY:
0.000149
AC XY:
73
AN XY:
490648
show subpopulations
African (AFR)
AF:
0.000103
AC:
2
AN:
19484
American (AMR)
AF:
0.00
AC:
0
AN:
9812
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
11798
East Asian (EAS)
AF:
0.0000615
AC:
1
AN:
16248
South Asian (SAS)
AF:
0.0000831
AC:
2
AN:
24072
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
28032
Middle Eastern (MID)
AF:
0.00157
AC:
4
AN:
2542
European-Non Finnish (NFE)
AF:
0.000136
AC:
119
AN:
877002
Other (OTH)
AF:
0.000264
AC:
10
AN:
37892
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
7
14
22
29
36
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000888
AC:
13
AN:
146456
Hom.:
0
Cov.:
31
AF XY:
0.0000701
AC XY:
5
AN XY:
71300
show subpopulations
African (AFR)
AF:
0.000125
AC:
5
AN:
40048
American (AMR)
AF:
0.0000676
AC:
1
AN:
14800
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3404
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4990
South Asian (SAS)
AF:
0.000211
AC:
1
AN:
4734
European-Finnish (FIN)
AF:
0.000111
AC:
1
AN:
8996
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
290
European-Non Finnish (NFE)
AF:
0.0000604
AC:
4
AN:
66246
Other (OTH)
AF:
0.000490
AC:
1
AN:
2040
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
ExAC
AF:
0.0000822
AC:
1

ClinVar

ClinVar submissions
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Inborn genetic diseases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.073
BayesDel_addAF
Benign
-0.15
T
BayesDel_noAF
Benign
-0.45
CADD
Benign
18
DANN
Benign
0.77
DEOGEN2
Benign
0.14
T
Eigen
Benign
-0.19
Eigen_PC
Benign
-0.22
FATHMM_MKL
Benign
0.63
D
LIST_S2
Benign
0.36
T
M_CAP
Benign
0.011
T
MetaRNN
Benign
0.080
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.34
N
PhyloP100
0.63
PrimateAI
Pathogenic
0.80
D
PROVEAN
Benign
-0.87
N
REVEL
Benign
0.059
Sift
Benign
0.28
T
Sift4G
Uncertain
0.034
D
Polyphen
0.82
P
Vest4
0.38
MutPred
0.21
Gain of glycosylation at Q34 (P = 0.0103)
MVP
0.65
ClinPred
0.12
T
GERP RS
2.9
PromoterAI
0.0066
Neutral
Varity_R
0.18
gMVP
0.22
Mutation Taster
=73/27
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs767066861; hg19: chr3-63898375; API